• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

haemophilia - Articles and news items

freeline

UCL Technology Fund invests £1m in gene therapy company, Freeline

Industry news / 20 June 2016 / Victoria White, Digital Content Producer

Freeline is developing and commercialising gene therapies for bleeding and other life threatening or debilitating disorders…

haemophilia B

EC approves Alprolix for the treatment of haemophilia B

Industry news / 13 May 2016 / Victoria White, Digital Content Producer

The European Commission has approved Alprolix (rFIXFc) for the treatment of haemophilia B and maintained its orphan designation…

haemophilia

Biogen announces plans to spin off its haemophilia business

Industry news / 3 May 2016 / Victoria White, Digital Content Producer

The new company, to be named at a later date, will focus on the discovery and development of therapies for the treatment of haemophilia…

haemophilia B

Battle set for the European haemophilia B treatment market, says GlobalData

Industry news / 23 March 2016 / Victoria White

CSL Behring’s Idelvion and Sobi/Biogen’s Alprolix will compete intensely for a share of the haemophilia B market following their expected European approvals…

 

Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionWATCH NOW
+ +